Vasoactive hemoglobin solution improves survival in hemodilution followed by hemorrhagic shock
- PMID: 21336111
- PMCID: PMC3318980
- DOI: 10.1097/CCM.0b013e3182120cdb
Vasoactive hemoglobin solution improves survival in hemodilution followed by hemorrhagic shock
Abstract
Objective: To compare survival after exchange transfusion followed by hemorrhage using: 1) the vasoactive, oxygen-carrying, bovine hemoglobin-based blood substitute Oxyglobin (Biopure, 12.9 g hemoglobin/dL); and 2) the hydroxyethyl starch plasma expander Hextend (high molecular weight and low degree of substitution, 6%).
Design: Comparison between treatments.
Setting: Laboratory.
Subjects: Awake hamster chamber window model.
Interventions: Fifty percent blood volume exchange transfusion followed by a 60% hemorrhage over 1 hr, followed by 1 hr of observation. Measurement of blood gases, mean arterial blood pressure, functional capillary density, arteriolar and venular diameter, and Po2 tension distribution.
Measurements and main results: Survival with Oxyglobin was 100% and only 50% for the Hextend group. Vasoconstriction was evident in the microcirculation. Mean arterial pressure was higher in the Oxyglobin group. Functional capillary density was significantly reduced, although to a lesser extent by Oxyglobin. There was no difference in microvascular Po2 distribution after 1 hr of shock between groups.
Conclusions: Higher mean arterial pressure during the initial stages of hemorrhage could be due to vasoconstriction in the Oxyglobin group as compared to the Hextend group. It is concluded that the pressor effect due to a vasoactive oxygen carrier may be beneficial in maintaining perfusion in conditions of severe hemodilution followed by hypovolemia.
Conflict of interest statement
The remaining authors have not disclosed any potential conflicts of interest.
Figures





Comment in
-
Dilate, dilute, constrict, or else in treating hemorrhage?Crit Care Med. 2011 Jun;39(6):1591-2. doi: 10.1097/CCM.0b013e3182185480. Crit Care Med. 2011. PMID: 21610642 No abstract available.
References
-
- Reah G, Bodenham AR, Mallick A, et al. Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients. Crit Care Med. 1997;25(9):1480–1488. - PubMed
-
- Alayash AI. Oxygen therapeutics: Can we tame haemoglobin? Nature Reviews Drug Discovery. 2004;3:152–159. - PubMed
-
- Stadlbauer KH, Wenzel V, Krismer AC, et al. Vasopressin during uncontrolled hemorrhagic shock: less bleeding below the diaphragm, more perfusion above. Anesth Analg. 2005;101:830–832. - PubMed
-
- Cabrales P, Tsai AG, Intaglietta M. Microvascular pressure and functional capillary density in extreme hemodilution with low and high plasma viscosity expanders. Am J Physiol. 2004;287:H363–H373. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources